Pt(IV) compounds include a mitochondria targeting moiety. One example of a Pt(IV) compound having a mitochondria targeting moiety is a Pt(IV) cisplatin-based compound. Upon reduction, the mitochondrial targeting moieties are released resulting in a Pt(II) therapeutic agent. Pt(IV) compounds including a mitochondria targeting moiety can be included in nanoparticles. The compounds or nanoparticles can be used to treat, for example, cancer.
申请公布号
WO2015157409(A1)
申请公布日期
2015.10.15
申请号
WO2015US24909
申请日期
2015.04.08
申请人
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.;DHAR, SHANTA;PATHAK, RAKESH;MARRACHE, SEAN